Whitener Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Whitener Capital Management’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,000	Closed	-$28.2K	–	162
2023 Q4	$28.2K	Hold	12,000	–	–	0.01%	151
2023 Q3	$22.3K	Hold	12,000	–	–	0.01%	144
2023 Q2	$31.4K	Hold	12,000	–	–	0.01%	145
2023 Q1	$19.6K	Hold	12,000	–	–	0.01%	136
2022 Q4	$16K	Hold	12,000	–	–	0.01%	136
2022 Q3	$18K	Hold	12,000	–	–	0.01%	135
2022 Q2	$18K	Hold	12,000	–	–	0.01%	136
2022 Q1	$30K	Hold	12,000	–	–	0.01%	144
2021 Q4	$35K	Buy	+12,000	New	+$25.9K	0.01%	146
2021 Q3	–	Sell	-14,000	Closed	-$56K	–	141
2021 Q2	$56K	Buy	+14,000	New	+$53.4K	0.02%	138

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

Whitener Capital Management's XERS Position: Q1 2024 in Review

Whitener Capital Management sold out of Xeris Biopharma Holdings (XERS) in Q1 2024, closing a stake of 12,000 shares — an estimated $28.2K sold.

Whitener Capital Management first reported a position in XERS in Q2 2021 and held it in 10 quarters. The position peaked at $56K in Q2 2021. 143 funds tracked by Wall St. Rank hold XERS as of Q1 2024.

Whitener Capital Management reported no remaining Xeris Biopharma Holdings position as of Q1 2024 after selling out during the quarter.
Whitener Capital Management sold 12,000 Xeris Biopharma Holdings shares in Q1 2024, an estimated $28.2K.
Whitener Capital Management first reported a position in Xeris Biopharma Holdings in Q2 2021 and held it in 10 quarters.
Whitener Capital Management's Xeris Biopharma Holdings position peaked at $56K in Q2 2021.
143 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2024.

Based on Whitener Capital Management's 13F filing for Q1 2024, filed 16 Apr 2024.